What’s New

Latest News

News
Gene Signature May Help Predict Treatment-Free Remission in CML
09/21/2026
Hannah Musick
A 50-gene transcriptomic signature predicted the likelihood of sustained treatment-free remission after tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia, potentially supporting more individualized treatment...
A 50-gene transcriptomic signature predicted the likelihood of sustained treatment-free remission after tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia, potentially supporting more individualized treatment...
A 50-gene transcriptomic...
09/21/2026
First Report Managed Care
First Report Managed Care
News
Community Care Utilization Among US Veterans
09/21/2026
Rebecca Amrick
US veterans who visited community urgent care clinics were more likely to receive subsequent non-Veterans Health Administration (VHA) specialty care than those who initially visited VHA urgent care clinics.
US veterans who visited community urgent care clinics were more likely to receive subsequent non-Veterans Health Administration (VHA) specialty care than those who initially visited VHA urgent care clinics.
US veterans who visited...
09/21/2026
Veterans Health Today
Veterans Health Today
News
Tafasitamab Plus Lenalidomide and R-CHOP Significantly Improves PFS in High-Risk Diffuse Large B-Cell Lymphoma or High-Grade B-Cell Lymphoma
09/21/2026
Emily Estrada
Results from the phase 3 FrontMIND trial demonstrated that adding tafasitamab and lenalidomide to R-CHOP significantly improved progression-free survival in previously untreated patients with high-risk diffuse large B-cell lymphoma or...
Results from the phase 3 FrontMIND trial demonstrated that adding tafasitamab and lenalidomide to R-CHOP significantly improved progression-free survival in previously untreated patients with high-risk diffuse large B-cell lymphoma or...
Results from the phase 3...
09/21/2026
Oncology
Oncology
a woman holds her hands as she looks at her computer screen
Conference Coverage
Semaglutide Linked to Fewer Cognitive Symptoms in Psychiatric Disorders
09/19/2026
Maria Mantas
Semaglutide initiation was associated with fewer clinician-recorded cognitive signs and symptoms among adults with psychiatric disorders, according to a poster presented at Psych Congress.
Semaglutide initiation was associated with fewer clinician-recorded cognitive signs and symptoms among adults with psychiatric disorders, according to a poster presented at Psych Congress.
Semaglutide initiation was...
09/19/2026
Psych Congress Network
Psych Congress Network
News
Povidone and Proparacaine Ophthalmic Solution Recalled Due to Drug Subpotency
09/17/2026
Rebecca Amrick
Povidone iodine and proparacaine hydrochloride ophthalmic solution is under a voluntary Class III recall due to drug subpotency, affecting 772 bottles.
Povidone iodine and proparacaine hydrochloride ophthalmic solution is under a voluntary Class III recall due to drug subpotency, affecting 772 bottles.
Povidone iodine and proparacaine...
09/17/2026
Pharmacy Learning Network
Pharmacy Learning Network
News
Anemia Associated With Higher Mortality and AML Transformation Risk in Myelofibrosis
09/17/2026
Rebecca Amrick
Researchers found that the presence of anemia is likely to increase the risk of mortality and acute myeloid leukemia (AML) transformation among patients with myelofibrosis, indicating anemia as a potential prognostic marker.
Researchers found that the presence of anemia is likely to increase the risk of mortality and acute myeloid leukemia (AML) transformation among patients with myelofibrosis, indicating anemia as a potential prognostic marker.
Researchers found that the...
09/17/2026
Journal of Clinical Pathways
Journal of Clinical Pathways

Latest Research

september 2026
The Dermatologist
Dermatology in the Digital Age: How Technology Is Transforming Clinical Practice
Vol. 34, Issue 6, Issue September 2026
JIC digital issue cover
Journal of Invasive Cardiology
Imaging Insights Into Endothelial Response: Cardiac Computed Tomography Assessment of WATCHMAN FLX and FLX Pro
J INVASIVE CARDIOL 2026;38(9). doi:10.25270/jic/26.00003. Epub May 29, 2026.
Vol. 38, Issue 9, Issue September 2026

HMP Global Learning Network

Featured Interviews

Raj Chovatiya
Videos
Chronic Spontaneous Urticaria: Type 2 Inflammation and Mast Cell Hyperreactivity
09/01/2026
Raj Chovatiya, MD, PhD; Riya Gandhi, MA
Dr Raj Chovatiya explains how type 2 inflammation drives mast cell activation in chronic spontaneous urticaria (CSU), highlighting the roles of IL-4, IL-13, and IgE in both immune and neuroimmune pathways.
Dr Raj Chovatiya explains how type 2 inflammation drives mast cell activation in chronic spontaneous urticaria (CSU), highlighting the roles of IL-4, IL-13, and IgE in both immune and neuroimmune pathways.
Dr Raj Chovatiya explains how...
09/01/2026
The Dermatologist
Desiree Matthews, PMHNP-BC
Clinical Pearls
Individualizing Initial Antidepressant Selection for Major Depressive Disorder
08/31/2026
Desiree Matthews, PHMNP-BC
Desiree Matthews, PMHNP-BC, offers a framework for choosing an initial antidepressant agent for major depressive disorder.
Desiree Matthews, PMHNP-BC, offers a framework for choosing an initial antidepressant agent for major depressive disorder.
Desiree Matthews, PMHNP-BC,...
08/31/2026
Psych Congress NP Institute
A “sensory ambulance” is now actively in use by the neo-peds transport team from Golisano Children's Hospital in Southwest Florida. Here’s a behind-the-scenes tour as to how insights from parents, children, and EMS professionals helped create and customize the ambulance.
Videos
Pediatric Video Tutorial: 'Sensory Ambulances'—Amazing for Autism
08/25/2026
Scott DeBoer, RN, MSN, CPEN, CEN, CCRN, CFRN
A “sensory ambulance” is now actively in use by the neo-peds transport team from Golisano Children's Hospital in Southwest Florida.
A “sensory ambulance” is now actively in use by the neo-peds transport team from Golisano Children's Hospital in Southwest Florida.
A “sensory ambulance” is now...
08/25/2026
EMSWorld
Amy paller
Videos
Clinical Management of Atopic Dermatitis Across Childhood
08/01/2026
Amy S. Paller, MD, MS; Riya Gandhi, MA
Dr Amy Paller discusses how advances in understanding type 2 inflammation are transforming pediatric atopic dermatitis care.
Dr Amy Paller discusses how advances in understanding type 2 inflammation are transforming pediatric atopic dermatitis care.
Dr Amy Paller discusses how...
08/01/2026
The Dermatologist
Murugiah_title_slide
Author Interview
Adoption of Intravascular Imaging Use Among Intermediate to High-Volume Operators in the United States From 2019 to 2023: A Medicare Data Analysis — An Interview With Karthik Murugiah, MBBS, MHS
07/31/2026
Karthik Murugiah, MBBS, MHS
Dr Karthik Murugiah shares background and insights on his article, “Adoption of Intravascular Imaging Use Among Intermediate to High-Volume Operators in the United States From 2019 to 2023: A Medicare Data Analysis.”
Dr Karthik Murugiah shares background and insights on his article, “Adoption of Intravascular Imaging Use Among Intermediate to High-Volume Operators in the United States From 2019 to 2023: A Medicare Data Analysis.”
Dr Karthik Murugiah shares...
07/31/2026
Journal of Invasive Cardiology
Erin Crown, MHS, PA-C, CAQ-Psychiatry
Clinical Pearls
When to Adjust or Augment Antidepressant Treatment in MDD
07/31/2026
Erin Crown, MHS, PA-C, CAQ
In this video, Erin Crown, MHS, PA-C, CAQ-Psychiatry, shares her approach to deciding when to augment rather than switch antidepressant therapy. 
In this video, Erin Crown, MHS, PA-C, CAQ-Psychiatry, shares her approach to deciding when to augment rather than switch antidepressant therapy. 
In this video, Erin Crown, MHS,...
07/31/2026
Psych Congress NP Institute
Thumbnail
Videos
How to Implement Subcutaneous Immunotherapy for Providers
07/30/2026
Meagan Farnie, BSN, RN; Pablo Saenz, PharmD; Dean Tuel; Jeff Yorio, MD
The panel outlines how to operationalize subcutaneous immunotherapy in clinical practice, covering efficacy and safety review, insurance and workflow considerations, and strategies for educating patients and care teams during the transition.
The panel outlines how to operationalize subcutaneous immunotherapy in clinical practice, covering efficacy and safety review, insurance and workflow considerations, and strategies for educating patients and care teams during the transition.
The panel outlines how to...
07/30/2026
Oncology
Bruce Sands
Expert Insights
Bruce Sands, MD, on Results from DUET-CD
07/19/2026
Bruce E. Sands, MD, MS
Dr Sands reviews the results of the DUET-CD study of combination therapy with guselkumab and golimumab in patients with Crohn's disease, which showed a significant increase in efficacy for the combination versus either drug independently.
Dr Sands reviews the results of the DUET-CD study of combination therapy with guselkumab and golimumab in patients with Crohn's disease, which showed a significant increase in efficacy for the combination versus either drug independently.
Dr Sands reviews the results of...
07/19/2026
Advances in Inflammatory Bowel Disease Network
Part 5 panel
Videos
Safety Monitoring in High-Risk CSCC
06/24/2026
Christopher Barker, MD; Krupal Patel, MD, MSc, FRCSC, FACS; John Strasswimmer, MD, PhD, FAAD, FACMS; Deborah J.L. Wong, MD, PhD
The roundtable discussion concludes with a review of the safety profile of adjuvant cemiplimab and best practices for monitoring and managing adverse events in patients with high-risk CSCC, with an emphasis on multidisciplinary follow-up,...
The roundtable discussion concludes with a review of the safety profile of adjuvant cemiplimab and best practices for monitoring and managing adverse events in patients with high-risk CSCC, with an emphasis on multidisciplinary follow-up,...
The roundtable discussion...
06/24/2026
The Dermatologist
Oncology Learning Network Live Daily
Discussion: CAR-T Cell Therapy Access and Earlier Referral
06/19/2026
Beth Faiman, CNP, PhD; Donna Catamero, ANP-BC, OCN, CCRC
Clinicians discuss key updates in multiple myeloma and plasma cell disorders.
Clinicians discuss key updates in multiple myeloma and plasma cell disorders.
Clinicians discuss key updates...
06/19/2026
Oncology

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use